Pacific Northwest


Liver-Related Information

In Your Area

Simply Speaking HBV: An Expert Educators CME Lecture Series (Tacoma)

The American Liver Foundation Pacific Northwest Division invites you to join us for "Clinical Perspectives in the Management of Chronic HBV Infection: A Case-Based Approach"

December 4th, 2012 - December 4th, 2012 (6:30pm - 8:30pm)

Contact: Regina Stacy (Email)
Phone: (813) 891-6999 | Register | More Information

Hosted by American Liver Foundation
El Gaucho Restaurant - Directions
2119 Pacific Avenue
Tacoma, WA 98402

Activity Overview:
This course is designed for physicians treating hepatitis B patients. Physician assistants, nurse practitioners, registered nurses, and pharmacists are also welcome to participate.

Guest Educator:
Atif Zaman, MD, MPH
Professor of Medicine
Section Chief, Division of Gastroenterology & Hepatology
Oregon Health & Science University
Portland, OR

Learning Objectives (CME/CE):
Upon completion of this activity, the participant intends to incorporate the following objectives into their practice of medicine:

  • Screen and test for hepatitis B virus (HBV) infection in my patients at high risk for HBV infection according to the recommendations from the Centers for Disease Control and Prevention.
  • Diagnose HBV infection using the tests recommended by the American Association for the Study of Liver Diseases (AASLD).
  • Counsel my patients with chronic HBV on the impact of current antiviral therapies on the rate of HBsAg seroconversion, disease progression, and the development of hepatocellular carcinoma.
  • Appropriately select anti-HBV therapy in my HBV-infected patients who are candidates for therapy according to the AASLD recommendations.

Learning Objectives (CPE):
Upon completion of this activity, the pharmacist should be able to:

  • Discuss the screening and testing recommendations for hepatitis B virus (HBV) infection according to the recommendations from the Centers for Disease Control and Prevention.
  • Discuss tests used to diagnose HBV infection as recommended by the American Association for the Study of Liver Diseases (AASLD).
  • Counsel my patients with chronic HBV on the impact of current antiviral therapies on the rate of HBsAg seroconversion, disease progression, and the development of hepatocellular carcinoma.
  • Discuss anti-HBV therapy in my HBV-infected patients who are candidates for therapy according to the AASLD recommendations.

To Register:
To register for this event, please visit www.simplyspeakinghbv.com and use the event code 23200221 (an invitation code does not apply). If you have any questions, please contact Regina Stacy with Practice Point Communications at (813) 891-6999 rstacy@practicepointinc.com or Jeffrey Petrovic with the American Liver Foundation in Seattle at (212) 668-1000 x2801, jpetrovic@liverfoundation.org.

Page updated: November 26th, 2012